BG60317B2 - Инденоиндолови съединения - Google Patents

Инденоиндолови съединения Download PDF

Info

Publication number
BG60317B2
BG60317B2 BG095667A BG9566791A BG60317B2 BG 60317 B2 BG60317 B2 BG 60317B2 BG 095667 A BG095667 A BG 095667A BG 9566791 A BG9566791 A BG 9566791A BG 60317 B2 BG60317 B2 BG 60317B2
Authority
BG
Bulgaria
Prior art keywords
cis
tetrahydro
group
formula
indole
Prior art date
Application number
BG095667A
Other languages
Bulgarian (bg)
English (en)
Inventor
Malcolm Sainsbury
Howard Shertzer
Original Assignee
University Of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Bath filed Critical University Of Bath
Publication of BG60317B2 publication Critical patent/BG60317B2/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG095667A 1989-06-22 1991-12-20 Инденоиндолови съединения BG60317B2 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8902274A SE8902274D0 (sv) 1989-06-22 1989-06-22 Indenoidole compounds ii
PCT/GB1990/000949 WO1990015799A1 (en) 1989-06-22 1990-06-20 Indenoindole compounds ii

Publications (1)

Publication Number Publication Date
BG60317B2 true BG60317B2 (bg) 1994-07-25

Family

ID=20376370

Family Applications (1)

Application Number Title Priority Date Filing Date
BG095667A BG60317B2 (bg) 1989-06-22 1991-12-20 Инденоиндолови съединения

Country Status (34)

Country Link
EP (1) EP0409410B1 (is)
JP (1) JP3064411B2 (is)
KR (1) KR920702679A (is)
CN (1) CN1033029C (is)
AT (1) ATE135688T1 (is)
BG (1) BG60317B2 (is)
CA (1) CA2060897A1 (is)
DD (1) DD297960A5 (is)
DE (1) DE69025998T2 (is)
DK (1) DK0409410T3 (is)
DZ (1) DZ1428A1 (is)
ES (1) ES2084660T3 (is)
FI (1) FI100800B (is)
GR (1) GR3019779T3 (is)
HR (1) HRP920903B1 (is)
HU (1) HUT59097A (is)
IE (1) IE74682B1 (is)
IL (1) IL94830A (is)
IS (1) IS3590A7 (is)
LT (1) LT3675B (is)
LV (1) LV10253B (is)
MX (1) MX21244A (is)
MY (1) MY107311A (is)
NO (1) NO177932C (is)
NZ (1) NZ234175A (is)
PL (1) PL167761B1 (is)
PT (1) PT94468B (is)
RO (1) RO111573B1 (is)
RU (1) RU2104270C1 (is)
SE (1) SE8902274D0 (is)
SI (1) SI9011223B (is)
WO (1) WO1990015799A1 (is)
YU (1) YU122390A (is)
ZA (1) ZA904827B (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9301104D0 (en) * 1990-10-16 1993-07-28 Univ Bath Method for producing tetrahydro-indeno-indole derivatves and pharmaceutical preparatives containing it
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
SE9302431D0 (sv) * 1993-07-16 1993-07-16 Ab Astra Use of indenoindole compounds
CA2128283A1 (fr) * 1993-07-20 1995-01-21 Paul Caubere (thia)cycloalkyl¬b|indoles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6288099B1 (en) 1998-12-04 2001-09-11 American Home Products Corporation Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
JP2002531569A (ja) * 1998-12-04 2002-09-24 ワイス 新規なカリウムチャンネル開放物質としての置換ベンゾフラノインドール及びインデノインドール
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2612442A1 (en) 2005-07-14 2007-01-18 Irm Llc Heterotetracyclic compounds as tpo mimetics
DE102006047231B4 (de) * 2006-10-04 2009-02-12 Hemmerling, Hans-Jörg, Dr. Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika
EP2722042B1 (en) * 2011-06-16 2019-05-29 Korea Research Institute of Chemical Technology Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
PT3882244T (pt) 2012-12-14 2025-04-04 Univ Leuven Kath Composto, sal farmaceuticamente aceitável ou isómero ótico do mesmo, método para a sua preparação e composição farmacêutica para prevenção ou tratamento de doenças virais que contenha o mesmo como ingrediente ativo
KR102894005B1 (ko) 2020-04-20 2025-12-03 노파르티스 아게 항바이러스 1,3-다이-옥소-인덴 화합물
CN115916763B (zh) 2020-04-20 2025-06-03 诺华股份有限公司 抗病毒素1,3-二氧代茚化合物

Also Published As

Publication number Publication date
MX21244A (es) 1994-03-31
IE902247A1 (en) 1991-01-16
CN1033029C (zh) 1996-10-16
PL285752A1 (en) 1991-03-11
ES2084660T3 (es) 1996-05-16
NO915049D0 (no) 1991-12-20
HRP920903B1 (en) 1998-06-30
CN1051554A (zh) 1991-05-22
HRP920903A2 (hr) 1994-04-30
SI9011223B (sl) 1998-08-31
HUT59097A (en) 1992-04-28
NO915049L (no) 1992-02-21
IL94830A0 (en) 1991-04-15
SE8902274D0 (sv) 1989-06-22
NO177932B (no) 1995-09-11
EP0409410A1 (en) 1991-01-23
PT94468B (pt) 1997-12-31
DE69025998T2 (de) 1996-08-08
DE69025998D1 (de) 1996-04-25
LTIP912A (en) 1995-03-27
HU904825D0 (en) 1992-03-30
YU122390A (sh) 1992-09-07
IE74682B1 (en) 1997-07-30
WO1990015799A1 (en) 1990-12-27
MY107311A (en) 1995-11-30
IS3590A7 (is) 1990-12-23
EP0409410B1 (en) 1996-03-20
FI100800B (fi) 1998-02-27
DD297960A5 (de) 1992-01-30
RU2104270C1 (ru) 1998-02-10
ZA904827B (en) 1991-04-24
JP3064411B2 (ja) 2000-07-12
CA2060897A1 (en) 1990-12-23
GR3019779T3 (en) 1996-07-31
DZ1428A1 (fr) 2004-09-13
NZ234175A (en) 1992-12-23
JPH04505923A (ja) 1992-10-15
KR920702679A (ko) 1992-10-06
LV10253B (en) 1995-04-20
LV10253A (lv) 1994-10-20
SI9011223A (en) 1997-10-31
FI915999A0 (fi) 1991-12-19
DK0409410T3 (da) 1996-04-29
IL94830A (en) 1996-07-23
IE902247L (en) 1990-12-22
PT94468A (pt) 1991-02-08
PL167761B1 (pl) 1995-10-31
AU5836990A (en) 1991-01-08
LT3675B (en) 1996-01-25
AU644084B2 (en) 1993-12-02
RO111573B1 (ro) 1996-11-29
NO177932C (no) 1995-12-20
ATE135688T1 (de) 1996-04-15

Similar Documents

Publication Publication Date Title
KR900003492B1 (ko) 피페라지닐-헤테로시클릭 화합물
EP0580502B1 (fr) 3-(hydroxybenzylidényl)-indoline-2-ones, et les compositions pharmaceutiques qui les contiennent
EP2364298B1 (en) Quinolone compound and pharmaceutical composition
EP0409410B1 (en) Indenoindole compounds
US5185360A (en) Dihydroindenoindole compounds and methods for using the same
EP0527081A1 (fr) Nouvelles pipérazinylalcoyl-3 dihydro-2,3 4H-benzoxazine-1,3 ones-4 substituées, leur préparation et leur application en thérapeutique
EP0239476B1 (fr) Dérivés du pyridoindole, leur application à titre de médicaments et les compositions les renfermant
US5516788A (en) Tetrahydroindenoindole compounds useful in the treatment of conditions associated with free radical formation
AP339A (en) Indenoindoles compounds.
EP0433167B1 (fr) Nouveaux dérivés de la pipéridine, leur procédé de préparation et les compositions pharmaceutiques les renfermant
EP1129097B1 (en) Novel type condensed pyridazinone compounds
AU644084C (en) Indenoindole compounds II
EP0449728A1 (fr) Nouveaux dérivés de la 4H-pyrrolo (1,2-a)thieno(2,3-f) diazépine(1,4), leur procédé de préparation et les compositions pharmaceutiques les renfermant
HK1156542B (en) Quinolone compound and pharmaceutical composition